RESEARCH DOMICILATION/COMMERCIALIZATION

We are open to domicile our discoveries/investments to any of our strategic partners’ country(ies) of operation for transparency/trust/shared-interest and we are also open to handover our discoveries on gratis after Total Expertise Transfer pact for Clinical Trials in the country of our strategic partners while we remain in Africa till the Clinical data of our APIs validate our Preclinical data